GPT and Hepatic fibrosis: Prophylactic (from the 9th week) but not therapeutic (from the 13th week) administration of OCA significantly reduced serum ALT and AST levels (Fig. 2b), and ameliorated liver fibrosis (Fig. 2c, d).